A Corrective and Preventive Action (CAPA) is a central component of any Quality Management System (QMS) in the pharmaceutical industry. It represents a systematic approach to investigating, addressing, and preventing deviations, non-conformities, or other undesirable quality issues. The process involves identifying the root cause (Root Cause Analysis), implementing corrective actions to resolve the immediate problem, and introducing preventive measures to avert recurrence.
In clinical research, CROs apply the CAPA process to findings from audits, inspections, monitoring reports, or internal quality controls. A robust CAPA process is crucial for maintaining GCP compliance and the continuous improvement of processes. It demonstrates a proactive commitment to quality to regulatory authorities. Modern eQMS systems automate CAPA management, from initiation through investigation and approval to effectiveness checks, ensuring that all steps are transparently documented and completed in a timely manner.